Skip to main content
Book cover

Clinical Benefits of Leukodepleted Blood Products

  • Book
  • © 1995

Overview

Part of the book series: Medical Intelligence Unit (MIUN)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

Keywords

About this book

Joseph Sweeney, Andrew Heaton he presence of allogeneic leukocytes in blood products received little T attention until the mid-1950s when these "passenger" cells were im­ plicated in the etiology of febrile transfusion reactions, and early strate­ gies based on centrifugation were developed to effect their removal. In recent decades and, particularly in the past five years, there has been an accumulation of literature implicating leukocytes in a wide variety of undesirable reactions to blood transfusion. White cells are the least numerous of the cellular elements in blood and ratios of white cells to platelets and white cells to red cells are ap­ proximately 1:15 to 1:1000 respectively. This ratio is maintained in whole blood, but may be altered slightly in the process of component prepara­ tion. Any production or processing step which intentionally decreases this ratio will result in a product which can be described as white cell depleted. It has, however, become more common to define the outcome as a residual white cell content, rather than a decrease in cellular ratios, although the latter makes more sense on theoretical grounds, since deple­ tion of white cells needs to be put in the context of any unintentional loss of red cells or platelets. The end result of this intentional processing step, therefore, is generally expressed as the residual absolute number of white cells or as the degree of difference in white cell content, the latter expressed as either a percentage change or as a logarithmic reduction.

Authors and Affiliations

  • The Miriam and Roger Williams Hospitals, Providence, USA

    Joseph Sweeney

  • Irwin Memorial Blood Center, San Francisco, USA

    Andrew Heaton

Bibliographic Information

  • Book Title: Clinical Benefits of Leukodepleted Blood Products

  • Authors: Joseph Sweeney, Andrew Heaton

  • Series Title: Medical Intelligence Unit

  • DOI: https://doi.org/10.1007/978-3-662-26538-3

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1995

  • Softcover ISBN: 978-1-57059-122-8Published: 01 January 1995

  • eBook ISBN: 978-3-662-26538-3Published: 29 June 2013

  • Edition Number: 1

  • Number of Pages: X, 198

  • Number of Illustrations: 15 b/w illustrations

  • Topics: Pharmacology/Toxicology

Publish with us